Publication date: Jul 01, 2026
The anticipated “tripledemic” during the 2023-2024 season-in which simultaneous epidemics of SARS-CoV-2, influenza, and respiratory syncytial virus were projected-ultimately fell short of early forecasts. Nevertheless, each virus remains a significant public health concern in its own right. This article reviews the microbiology, diagnosis, and treatment of these three pathogens (including the role of immunomodulatory therapies), as well as key considerations for hospital infection prevention in the care of critically ill patients. The piece highlights the clinical indistinguishability of these viral infections and acknowledges the evolving public health discourse surrounding the role of vaccination in preventing disease.
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | COVID-19 |
| disease | MESH | Influenza |
| disease | MESH | hospital infection |
| disease | MESH | critically ill |
| disease | MESH | viral infections |
| disease | MESH | Respiratory Syncytial Virus Infections |